Annexon, Inc. (ANNX) Operating Sales Margin

Symbol and logo of brand annexonbio.com (ANNX)

Amidst the fierce competition among biotech firms for leadership in complement therapy, the operating margin has become a key benchmark. The 0.00 metric reflects the latest value, providing a real-time assessment of the financial stability of Annexon, Inc. (ANNX). The company leverages a strong academic research staff and is focusing its resources on completing the final trials of the drug ANX005 for the treatment of Guillain-Barré syndrome.

ANNX: Annexon Operating Margin 07/04/2022 - 11/19/2026

Analytical breakdowns for Annexon (ANNX)

- share price and consensus valuation forecast:
General company analysis:ANNX, Annexon, Inc.
Core merchandise of annexonbio.com

The efficiency of Annexon, Inc. (ANNX) is driven by its ability to minimize capital expenditures through the outsourcing of production and testing. Operating margin is calculated as the ratio of operating profit to total revenue, reflecting the net profitability of the core business. Investors utilize this metric to identify hidden degradation in profitability before a decline in share prices. An analysis of the average monthly operating margin allows for an assessment of the stability of the asset-light model. The trend in this average monthly operating margin confirms the actual financial strength of the company.

Competing companies

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Operating Sales Margin Omeros Corp|Operating Sales Margin NGNE|ACIU: Operating Profit Rate|Operating Sales Margin VYGR (Voyager Corp)|Operating Sales Margin Neumora NMRA|Operating Profitability Scilex Holding Company, Inc. SCLX|Operating Profitability Margin Tevogen Bio Inc.|ACOG - Operating Profitability|Operating Profitability Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Operating Sales Margin|Cassava Sciences Inc (SAVA) - Operating Margin|Operating Sales Margin ASRT|Operating Margin coyatherapeutics.com|Operating Margin VTGN|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin